Orbital apex syndrome in rhino-orbito-cerebralmucormycosis (ROCM) – A prospective observational study


Original Article

Author Details : Yogeswari Alagappan, Mahalakshmi R P, Gnanaoli Meenakshi Sundaram, Niranjan Karthik Senthil Kumar*

Volume : 8, Issue : 3, Year : 2022

Article Page : 182-184

https://doi.org/10.18231/j.ijooo.2022.041



Suggest article by email

Get Permission

Abstract

Orbital apex syndrome (OAS) is an uncommon clinical presentation consisting of complete ophthalmoplegia with vision loss, involving cranial nerves II, III, IV, V, and VI. OAS may result from trauma, malignancy, infection, inflammation, or vascular origins. Aims of the study were to analyse the incidence and presentation of orbital apex syndrome in rhino-orbital mucormycosis in a tertiary care hospital. A total of 29 cases (4.1%) out of 696 cases of invasive ROCM with OAS as a presenting feature were documented. Amphotericin B in both retrobulbar and intravenous routes played a crucial role in arresting the spread of the disease allowing only 8 (27%) cases to show disease progression. FESS if done appropriately with efficient debridement of necrotic infective tissue can be a powerful tool in redirecting the course of disease for the better (only 2 of 8 patients with CST at the time of presentation had a history of FESS done prior. ROCM is a severe, emergent and fatal infection requiring multidisciplinary management. It may often present with OAS initially. Mucormycosis must be considered in such patients and timely aggressive management must be initiated to avoid disastrous morbidity and mortality.
 

Keywords: Orbital apex syndrome, Rhino-orbito-cerebral mucormycosis


How to cite : Alagappan Y, Mahalakshmi R P, Sundaram G M, Kumar N K S, Orbital apex syndrome in rhino-orbito-cerebralmucormycosis (ROCM) – A prospective observational study. IP Int J Ocul Oncol Oculoplasty 2022;8(3):182-184


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.







Article History

Received : 02-08-2022

Accepted : 14-08-2022


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/ 10.18231/j.ijooo.2022.041


Article Metrics






Article Access statistics

Viewed: 1159

PDF Downloaded: 1340